da Cunha Santos Gilda, Saieg Mauro A
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
Cancer Cytopathol. 2017 Jun;125(S6):455-464. doi: 10.1002/cncy.21850.
With increasing requests for the evaluation of prognostic and predictive molecular biomarkers, great attention must be paid to the preanalytical issues regarding sample quality and DNA/RNA yield from all different types of cytological preparations. The objectives of this review were: 1) to provide an update regarding the importance of specimen triage as well as specimen handling and collection; 2) to discuss the different cell preparations that can be used for molecular testing, their advantages and limitations; and 3) to highlight the strategies for biobanking cytology samples. Good-quality DNA/RNA can be harvested from fresh cells in cell suspensions, formalin-fixed paraffin-embedded cell blocks, archival stained smears, archival unstained cytospin preparations, liquid-based cytology slides, FTA cards, and cryopreserved cells. In contrast to formalin-fixed paraffin-embedded tissue specimens (small biopsies and surgical resections), the multitude of types of sample preparations as well as the diversity in sample collection and processing procedures make cytology an ideal specimen for most genomic platforms, with less DNA and RNA degradation and a purer sample, usually with a higher concentration of tumor cells. The broad incorporation of cytological specimens into clinical practice. A should increase the number of samples potentially available for molecular tests and avoid repeat invasive procedures for tissue procurement, thereby increasing patient safety. In this context, it is of utmost importance that cytopathologists become familiar with the variables that can affect test results and embrace the goal of excellence in sample quality. Cancer Cytopathol 2017;125(6 suppl):455-64. © 2017 American Cancer Society.
随着对预后和预测性分子生物标志物评估的需求不断增加,必须高度重视所有不同类型细胞学标本的分析前问题,包括样本质量以及DNA/RNA产量。本综述的目的是:1)提供关于标本分类以及标本处理和采集重要性的最新信息;2)讨论可用于分子检测的不同细胞标本、它们的优缺点;3)强调细胞学样本生物样本库的策略。高质量的DNA/RNA可以从细胞悬液中的新鲜细胞、福尔马林固定石蜡包埋细胞块、存档染色涂片、存档未染色细胞离心涂片、液基细胞学载玻片、FTA卡和冷冻保存细胞中获取。与福尔马林固定石蜡包埋组织标本(小活检和手术切除)不同,多种类型的样本制备以及样本采集和处理程序的多样性使细胞学成为大多数基因组平台的理想标本,DNA和RNA降解较少,样本更纯,通常肿瘤细胞浓度更高。将细胞学标本广泛纳入临床实践应增加可用于分子检测的样本数量,并避免重复进行侵入性组织获取程序,从而提高患者安全性。在这种情况下,细胞病理学家熟悉可能影响检测结果的变量并追求卓越的样本质量至关重要。《癌症细胞病理学》2017年;125(6增刊):455 - 64。©2017美国癌症协会